2 research outputs found

    LesĂ”es mĂșltiplas de osteoma cutis na face: terapĂȘutica minimamente invasiva em pacientes com sequela de acne - relato de casos Multiple injuries of osteoma skin in the face: therapeutical least invasive in patients with acne sequela - case report

    No full text
    Osteoma cutis Ă© a formação Ăłssea no interior da pele, podendo ser primĂĄria ou secundĂĄria. Única ou mĂșltipla, de tamanhos variados e acometendo ambos os sexos, Ă© uma lesĂŁo cutĂąnea rara, de etiopatogenia e classificação ainda discutidas. Nosso objetivo foi relatar o diagnĂłstico e a terapĂȘutica minimamente invasiva de lesĂ”es mĂșltiplas de osteoma cutis na face em pacientes com sequelas de acne. Fizemos a retirada dos osteomas com agulhas BD 0,70 x 25 22G1, sem anestĂ©sicos tĂłpicos ou injetĂĄveis no local. As pequenas incisĂ”es foram deixadas expostas, com pomada cicatrizante. Obteve-se um excelente resultado estĂ©tico em 15 dias.<br>Osteoma cutis is a bone formation in the dermis can to be primary or secondary forms. Only, multiples, many forms, occurring on either sex, they are a rare cutaneous disease. The pathogenesis and classification remains unclear. Our objective was the diagnostic and small invasive surgery treatment of the osteoma cutis multiple of the face, in patients as a sequel of acne. To remove the osteoma we used needle BD 0,70x25 22G1, without anesthetic topic or inject able site. The small wounds were exposed with scarring balsam. We got an excellent esthetic result after 15 days

    Fluorescence properties of curcumin-loaded nanoparticles for cell tracking

    No full text
    Bassam Felipe Mogharbel,1 Julio Cesar Francisco,1 Ana Carolina Irioda,1 Dilcele Silva Moreira Dziedzic,1 Priscila Elias Ferreira,1 Daiany de Souza,1 Carolina Maria Costa de Oliveira Souza,1 Nelson Bergonse Neto,2 Luiz Cesar Guarita-Souza,2 Celia Regina Cavichiolo Franco,3 Celso Vataru Nakamura,4 Vanessa Kaplum,4 Let&iacute;cia Mazzarino,5 Elenara Lemos-Senna,6 Redouane Borsali,7 Paula A Soto,8 Patricia Setton-Avruj,8 Eltyeb Abdelwahid,9 Katherine Athayde Teixeira de Carvalho1 1Cell Therapy and Biotechnology in Regenerative Medicine Department, Pel&eacute; Pequeno Pr&iacute;ncipe Institute, Child and Adolescent Health Research and Pequeno Pr&iacute;ncipe Faculty, Curitiba, Paran&aacute;, Brazil; 2Institute of Biological and Health Sciences, Pontifical Catholic University of Paran&aacute; (PUCPR), Centro de Ci&ecirc;ncias Biol&oacute;gicas e da Sa&uacute;de (CCBS), Curitiba, Brazil; 3Cell Biology Department, Federal University of Paran&aacute;, Curitiba, Paran&aacute;, Brazil; 4Department of Pharmaceutical Sciences, Universidade Estadual de Maring&aacute;, Maring&aacute;, Paran&aacute;, Brazil; 5Department of Pharmaceutical Sciences, NanoBioMat Laboratory, Federal University of Santa Catarina, Florian&oacute;polis, Santa Catarina, Brazil; 6Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florian&oacute;polis, Santa Catarina, Brazil; 7Centre de Recherches sur les Macromol&eacute;cules V&eacute;g&eacute;tales (CERMAV), Centre National de la Recherche Scientifique (CNRS), University Grenoble Alpes, F-38000, Grenoble, France; 8Instituto de Qu&iacute;mica y F&iacute;sicoqu&iacute;mica Biol&oacute;gica (IQUIFIB), Departament of Qu&iacute;mica Biol&oacute;gica, Facultad de Farmacia y B&iacute;oqu&iacute;mica, Universidad de Buenos Aires (UBA) Consejo nacional de Investigaciones Cient&iacute;ficas y T&eacute;cnicas (CONICET), Buenos Aires, Argentine; 9Feinberg School of Medicine, Feinberg Cardiovascular Research Institute, Northwestern University, Chicago, Il, USA Background: Posttransplant cell tracking, via stem cell labeling, is a crucial strategy for monitoring and maximizing benefits of cell-based therapies. The structures and functionalities of polysaccharides, proteins, and lipids allow their utilization in nanotechnology systems. Materials and methods: In the present study, we analyzed the potential benefit of curcumin-loaded nanoparticles (NPC) using Vero cells (in vitro) and NPC-labeled adipose-derived mesenchymal stem cells (NPC-ADMSCs) (in vivo) in myocardial infarction and sciatic nerve crush preclinical models. Thereafter, transplantation, histological examination, real time imaging, and assessment of tissue regeneration were done. Results: Transplanted NPC-ADMSCs were clearly identified and revealed potential benefit when used in cell tracking. Conclusion: This approach may have broad applications in modeling labeled transplanted cells and in developing improved stem cell therapeutic strategies. Keywords: mesenchymal stem cells, transplantation, cell marking, myocardium infarction, sciatic nerve crus
    corecore